The essential role of androgen receptor signalling in prostate tumorigenesis [ 2010 - 2013 ]

Also known as: Aberrant androgen receptor signalling and prostate cancer

Research Grant

[Cite as]

Researchers: Prof Wayne Tilley (Principal investigator) ,  A/Pr Lisa Butler Dr Tina Bianco-Miotto Prof Howard Scher

Brief description An urgent objective in prostate cancer clinical practice is to better predict disease course at diagnosis and to identify patients likely to develop metastatic (lethal) disease. We aim to identify clinically-relevant genes - gene pathways that are important in prostate cancer development and progression and which can be used to improve prediction of patient outcome. Prostate cancer management can be improved by tailoring treatments for individual patients.

Funding Amount $AUD 714,375.16

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]